The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities.
about
Quantitative Perfusion and Permeability Biomarkers in Brain Cancer from Tomographic CT and MR ImagesAquaporins and Brain TumorsClinical applications of susceptibility-weighted imaging in detecting and grading intracranial gliomas: a reviewAEG-1/MTDH/LYRIC: clinical significancePituicytoma, spindle cell oncocytoma, and granular cell tumor: clarification and meta-analysis of the world literature since 1893Pediatric astroblastoma: a rare case with a review of the literature.Neuroradiologic characteristics of astroblastoma and systematic review of the literature: 2 new cases and 125 cases reported in 59 publications.Radicol, a Novel Trinorguaiane-Type Sesquiterpene, Induces Temozolomide-Resistant Glioma Cell Apoptosis via ER Stress and Akt/mTOR Pathway Blockade.Fine-needle aspiration cytology of epithelioid malignant peripheral nerve sheath tumor: A case report and review of the literature.Surgical resection of skull-base chordomas: experience in case selection for surgical approach according to anatomical compartments and review of the literature.IDH mutant and 1p/19q co-deleted oligodendrogliomas: tumor grade stratification using diffusion-, susceptibility-, and perfusion-weighted MRICUEDC2 suppresses glioma tumorigenicity by inhibiting the activation of STAT3 and NF-κB signaling pathwayGliomatosis cerebri: clinical characteristics, management, and outcomes.EMMPRIN is an independent negative prognostic factor for patients with astrocytic glioma.Astroblastoma: beside being a tumor entity, an occasional phenotype of astrocytic gliomas?Low expression of insulin-like growth factor binding protein 7 associated with poor prognosis in human glioma.Decreased Expression of miR-15b in Human Gliomas is Associated with Poor Prognosis.Detection of a Distinctive Genomic Signature in Rhabdoid Glioblastoma, A Rare Disease Entity Identified by Whole Exome Sequencing and Whole Transcriptome SequencingPro-apoptotic effects of rHSG on C6 glioma cells.Lectins identify glycan biomarkers on glioblastoma-derived cancer stem cells.Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imagingMalignant adenohypophysis spindle cell oncocytoma with repeating recurrences and a high Ki-67 index.Ependymal tumors with oligodendroglioma like clear cells: Experience from a tertiary care hospital in PakistanCandidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma.Primary Glial and Neuronal Tumors of the Ovary or Peritoneum: A Clinicopathologic Study of 11 Cases.Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBMExpression and prognostic significance of CTBP2 in human gliomas.microRNA-149 targets caspase-2 in glioma progression.Long Term Surgical Outcome and Prognostic Factors of Atypical and Malignant Meningiomas.Antivascular endothelial growth factor antibody for treatment of glioblastoma multiformeA case of astroblastoma: Radiological and histopathological characteristics and a review of current treatment options.A biphasic tumor consisting of pilocytic astrocytoma with an anaplastic solitary fibrous tumor component in the pineal region: a case report and literature review.GBM's multifaceted landscape: highlighting regional and microenvironmental heterogeneity.Molecular and genetic pathways in gliomas: the future of personalized therapeutics.An unusual variant of anlage tumor of pineal region in an infant.Spinal myxopapillary ependymomas: a retrospective clinical and immunohistochemical study.Understanding how differentiation is maintained: lessons from the Drosophila brain.High expression of UBE2C is associated with the aggressive progression and poor outcome of malignant glioma.Mechanism of G9a inhibitor BIX‑01294 acting on U251 glioma cells.Lentivirus-mediated silencing of HSDL2 suppresses cell proliferation in human gliomas.
P2860
Q26743358-75281792-114E-49ED-B9DA-20926B5102B1Q26745578-35D50E73-2A1D-4390-B48A-CC033669A7F9Q26864367-238C5477-2AB9-420A-8426-6810802E0FD5Q27014932-A4DB3340-2333-4220-B79E-E2472DA6A1C9Q28249369-BA04D115-80A8-4B95-8092-5CBF47B9CE6EQ30572086-C53E9FFB-9C99-4999-9139-747163F475BAQ31069275-C264B8D4-C8C3-4645-8563-53DB35078164Q32181359-F31B225A-1C93-4389-9D40-79AF62344A11Q33275831-F7CF9F97-D5BF-43B8-8486-ABC2DCAD90ABQ33276302-B116AEEA-BBFA-438C-8DD3-045A870DA870Q33733375-A9246643-01B3-4304-953C-78EB121B659EQ33788036-5CF0C97C-643A-4078-831F-4B8879B9D468Q34035234-1B998BE2-250B-4FE1-BC54-798306C5E308Q34629446-D4A913F8-4DC9-430E-8737-7F039C02C383Q35130047-E22AE488-F215-4132-BA1A-EBA720BE9C5AQ35152197-00FB7A2C-11CC-4FED-BC1C-376BD4FBFD62Q35589764-73D4F3C4-DD41-46D7-9BD9-5BCE98B3EAE5Q36038003-447CF002-D81F-4DCF-8ABA-05C07D3F5322Q36124303-5EF0AAAD-6306-4A7A-A1F3-A0C6F814FD3CQ36181785-0E4F2155-9FDD-41FD-BD3A-E159CA42A4F4Q36258314-6591EB78-E64A-4FF2-8968-A62DEDACD1FCQ36259611-D19A79EE-57F3-4A9A-8EC0-A081AE8666FFQ36300721-E2AF2FE0-3F2A-4E56-AF08-4E7DA51060D4Q36528386-43E8658A-2DD6-488C-BEFA-452757B1748AQ36892843-C33AAA4D-A549-4EFF-B3C4-A535931853E2Q37014722-9070FEBB-CB3C-46E4-BC79-EA7131CF4D1FQ37288083-07C9F21E-EB99-41D4-8A54-A56B437A110AQ37295673-03E7B0C3-6888-4932-905E-58CA55A25362Q37352522-6F0160D8-D9EB-4517-8E18-22702DCED1D9Q37372416-F599DD6B-4B35-438F-BD99-1386E7CBEA70Q37585115-FF82FA56-2F57-465E-871D-2CD857A17109Q38043538-484A83F2-2166-41EF-BAA0-EA1533EEB202Q38197021-EAEA8F38-8242-4023-B960-8FD8F0935287Q38233171-3A5BE8F7-B917-44C2-A9E8-9D203CBBFD8DQ38482520-32F2BA0E-4993-436F-9EC5-E49E176C6FEEQ38636179-38B0BC3A-9777-490C-808A-1F377CFAD0B9Q38713936-E827D31A-13D9-43AA-A98A-1EE19707403DQ38721719-81D1077A-C15C-48DA-BC0D-E6B60B9BD5F2Q38737468-9612B022-88EC-4D57-A147-0C246947FA16Q38818624-0FBC75D8-7BAA-437B-9783-1C6E1C2080A5
P2860
The 2007 Revised World Health Organization (WHO) Classification of Tumours of the Central Nervous System: newly codified entities.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The 2007 Revised World Health ...... stem: newly codified entities.
@ast
The 2007 Revised World Health ...... stem: newly codified entities.
@en
The 2007 Revised World Health Organization
@nl
type
label
The 2007 Revised World Health ...... stem: newly codified entities.
@ast
The 2007 Revised World Health ...... stem: newly codified entities.
@en
The 2007 Revised World Health Organization
@nl
prefLabel
The 2007 Revised World Health ...... stem: newly codified entities.
@ast
The 2007 Revised World Health ...... stem: newly codified entities.
@en
The 2007 Revised World Health Organization
@nl
P1433
P1476
The 2007 Revised World Health ...... ystem: newly codified entities
@en
P2093
Bernd W Scheithauer
P304
P356
10.1111/J.1750-3639.2007.00084.X
P577
2007-07-01T00:00:00Z